BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 6541019)

  • 1. [Combination chemotherapy of advanced transitional cell carcinoma with cis-platinum, cyclophosphamide, adriamycin and 5-fluorouracil (CISCAF)].
    Fujioka H; Tada Y; Nakano E; Matsuda M; Osafune M; Sagawa S; Takaha M; Sonoda T
    Gan To Kagaku Ryoho; 1984 Aug; 11(8):1612-6. PubMed ID: 6541019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Sequential combination chemotherapy consisting of vincristine, peplomycin, methotrexate, cis-diamminedichloroplatinum (II), cytosine arabinoside and 5-fluorouracil, for advanced urothelial cancer].
    Yamauchi T; Hida S; Ooishi K; Okada K; Yoshida O
    Hinyokika Kiyo; 1985 Jul; 31(7):1093-104. PubMed ID: 2414981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Polychemotherapy treatment with cisplatin, adriamycin, 5-fluorouracil (FAP) and cisplatin, adriamycin and cyclophosphamide (CISCA) in advanced transitional carcinoma of the bladder].
    Sánchez Romero JA; Ramírez Ruiz F; Romero Fernández L; Pastor Gaitán P; Murillo Capitán E
    Actas Urol Esp; 1989; 13(4):240-2. PubMed ID: 2678934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Chemotherapy for advanced bladder cancer: clinical evaluation of chemotherapy for locally advanced or metastatic bladder cancer and adjuvant chemotherapy for deeply invasive bladder cancer following radical cystectomy].
    Uekado Y; Ogawa T; Yoshida T; Yamamoto S; Hirano A; Watanabe T; Shinka T; Ohkawa T
    Hinyokika Kiyo; 1985 Aug; 31(8):1365-70. PubMed ID: 3841260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Combination chemotherapy of cyclophosphamide, adriamycin and cisplatin in advanced urothelial cancer].
    Nakagawa S; Nakao M; Toyoda K; Nukui M; Takada H; Ebisui K; Watanabe H; Furusawa T; Maegawa M; Kaiho H
    Gan To Kagaku Ryoho; 1987 Nov; 14(11):3071-7. PubMed ID: 3674892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapeutic experiences of cis-diamminedichloroplatinum, adriamycin and 5-fluorouracil combination chemotherapy in advanced urothelial cancer, with special reference to adjuvant chemotherapy in invasive urothelial cancer].
    Ogawa O; Yoshimura N; Taniguchi T; Nishimura K; Nakagawa T
    Hinyokika Kiyo; 1986 Jun; 32(6):795-802. PubMed ID: 3766338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Combination chemotherapy of advanced bladder cancer].
    Kiyohara H
    Hinyokika Kiyo; 1986 Dec; 32(12):1925-30. PubMed ID: 3825829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Combination chemotherapy with cisplatin, ifosfamide and adriamycin in patients with advanced transitional cell carcinoma of the urinary tract].
    Yoshimoto J; Nasu Y; Akagi T; Obama T; Tsushima T; Ozaki Y; Matsumura Y; Ohmori H; Asahi T; Ohkita K
    Gan To Kagaku Ryoho; 1985 Jun; 12(6):1312-7. PubMed ID: 4039919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cyclophosphamide, adriamycin and cisplatinum combination chemotherapy for advanced urothelial and prostatic carcinoma].
    Tsukamoto T; Tanoguchi H; Nakazono M; Murai M; Tachibana M; Deguchi N; Baba S; Hata M; Jitsukawa S; Tazaki H
    Gan To Kagaku Ryoho; 1987 Dec; 14(12):3259-64. PubMed ID: 3688891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Combined therapy with 5-fluorouracil, doxorubicin, cis-diamminedichloroplatinum on advanced urothelial cancer].
    Kawai T; Washizuka M; Kihara K; Takahashi T; Sakata Y; Tai K; Nagayama T; Okada K; Kusuyama H; Ishii Y
    Nihon Gan Chiryo Gakkai Shi; 1987 Feb; 22(1):40-6. PubMed ID: 3611890
    [No Abstract]   [Full Text] [Related]  

  • 11. [Combination chemotherapy of 5-fluorouracil (5-FU), adriamycin (ADM), cis-diamminedichloroplatinum (II) (CDDP) and mitomycin C (MMC) (FAP.MMC) in advanced gastric cancer].
    Ozeki H; Ogawa M; Horikoshi N; Inoue K; Mukaiyama T; Nagamine D; Ito Y; Imajo K; Shinagawa K
    Gan To Kagaku Ryoho; 1988 Jan; 15(1):91-5. PubMed ID: 3122669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Chemotherapy of metastatic urothelial carcinoma].
    Kihara K; Sakuramoto T; Washizuka M; Kawai T; Ogawa M
    Gan To Kagaku Ryoho; 1982 Nov; 9(11):2046-7. PubMed ID: 6892194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A study of the use of methotrexate, vincristine, cis-platinum, cyclophosphamide, adriamycin, bleomycin (MVP-CAB) in metastatic transitional cell carcinoma].
    Fujii A; Den S; Nakamura I; Ohshima H; Nagata H; Izumi T; Takechi Y; Kawaida T; Kamidono S; Yasuno H
    Hinyokika Kiyo; 1987 May; 33(5):697-703. PubMed ID: 2444083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II trial of weekly paclitaxel, cisplatin plus infusional high dose 5-fluorouracil and leucovorin for metastatic urothelial carcinoma.
    Lin CC; Hsu CH; Huang CY; Cheng AL; Vogelzang NJ; Pu YS
    J Urol; 2007 Jan; 177(1):84-9; discussion 89. PubMed ID: 17162009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Complete remission of bladder cancer with multiple pulmonary metastases obtained by combined chemotherapy with cis-platinum, adriamycin and cyclophosphamide].
    Takigawa H; Odachi M; Kagawa S; Kurokawa K
    Gan To Kagaku Ryoho; 1985 Sep; 12(9):1877-9. PubMed ID: 4041165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Sequential combination chemotherapy consisting of vincristine, peplomycin, methotrexate, cis-diamminedichloroplatinum (II) and adriamycin in urothelial cancer].
    Konami T; Wakabayashi Y; Kim T; Ishida A; Arai Y; Konishi T; Pak K; Takeuchi H; Tomoyoshi T; Watanabe J
    Hinyokika Kiyo; 1989 Feb; 35(2):231-7. PubMed ID: 2472048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination chemotherapy including adriamycin for advanced transitional cell carcinoma of the urinary tract.
    Kotake T; Usami M; Miki T; Kuroda M; Obata K; Osafune M; Fujioka H; Takasugi Y
    Cancer Chemother Pharmacol; 1983; 11 Suppl():S38-42. PubMed ID: 6685580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Weekly paclitaxel and carboplatin against advanced transitional cell cancer after failure of a platinum-based regimen.
    Kouno T; Ando M; Yonemori K; Matsumoto K; Shimizu C; Katsumata N; Komiyama M; Okajima E; Matsuoka N; Fujimoto H; Fujiwara Y
    Eur Urol; 2007 Oct; 52(4):1115-22. PubMed ID: 17433855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas.
    Colón-Otero G; Marschke R; Camoriano JK; Sorensen JM; Sloan JA; Richardson RL
    Cancer J Sci Am; 1997; 3(5):297-302. PubMed ID: 9327154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5-Fluorouracil and interferon-alpha in chemotherapy refractory bladder carcinoma: an effective regimen.
    Logothetis CJ; Hossan E; Recondo G; Sella A; Ellerhorst J; Kilbourn R; Zukiwski A; Amato R
    Anticancer Res; 1994; 14(3B):1265-9. PubMed ID: 8067694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.